首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1448597

全球抗寄生蟲藥物市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Antiparasitic Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年02月01日 | 出版商:

Value Market Research | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球抗寄生蟲藥物市場需求預計將從 2023 年的 183 億美元增至 2032 年近 312.9 億美元，2024-2032 年研究期間CAGR為 6.14%。

抗寄生蟲藥是用來治療寄生蟲（包括原生動物、蠕蟲和節肢動物）引起的感染的藥物。這些藥物透過殺死或抑制宿主體內寄生蟲的生長來發揮作用。常見的例子包括抗瘧藥、驅蟲藥和抗原蟲藥。這些藥物對於對抗寄生蟲疾病、促進公共衛生工作和改善受影響個人的福祉至關重要。

市場動態

寄生蟲感染的流行、人們對被忽視的熱帶疾病的認知不斷提高以及藥物開發的進步等因素推動了抗寄生蟲藥物市場的發展。瘧疾、利甚曼病和蠕蟲感染等寄生蟲疾病的全球負擔推動了對有效抗寄生蟲藥物的需求。專注於消除寄生蟲病的政府措施和國際合作進一步促進了市場成長。發現新型抗寄生蟲藥物的研究和開發工作以及聯合療法的引入增強了治療選擇。市場也受到社會經濟因素的影響，因為寄生蟲感染對低收入地區的人口影響尤其嚴重。人們越來越重視「同一個健康」策略，該策略承認人類、動物和環境健康之間的相互聯繫，凸顯了抗寄生蟲藥物在全球健康計劃中的關鍵作用。這些藥物在解決和管理超越物種界限的健康挑戰方面發揮關鍵作用，有助於旨在改善全球整體公共衛生的綜合努力。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球抗寄生蟲藥物市場的各個細分市場進行了包容性評估。抗寄生蟲藥物產業的成長和趨勢為本研究提供了整體方法。

市場區隔

抗寄生蟲藥物市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

依疾病類型

愛滋病
肝炎
流感
結核病
瘧疾
HPV病毒

按最終用途

醫院
診所
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲抗寄生蟲藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。抗寄生蟲藥市場的主要參與者包括諾華公司、吉利德、葛蘭素史克公司、楊森製藥公司、羅氏公司、BioCryst Pharmaceuticals, Inc.、默克公司、勃林格殷格翰公司有限公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：抗寄生蟲藥物公司的競爭格局

抗寄生蟲藥市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Novartis AG.

公司簡介
公司收入
產品
最近的發展

Gilead

公司簡介
公司收入
產品
最近的發展

GlaxoSmithKline plc.

公司簡介
公司收入
產品
最近的發展

Janssen Pharmaceutical Inc.

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd.

公司簡介
公司收入
產品
最近的發展

BioCryst Pharmaceuticals Inc.

公司簡介
公司收入
產品
最近的發展

Merck & Co. Inc.

公司簡介
公司收入
產品
最近的發展

Boehringer Ingelheim GmbH.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113746

The global demand for Antiparasitic Drugs Market is presumed to reach the market size of nearly USD 31.29 Billion by 2032 from USD 18.3 Billion in 2023 with a CAGR of 6.14% under the study period 2024 - 2032.

Antiparasitic drugs are medications designed to treat infections caused by parasites, including protozoa, helminths, and arthropods. These drugs work by either killing or inhibiting the growth of parasites within the host organism. Common examples include antimalarials, anthelmintics, and antiprotozoals. These drugs are essential in combating parasitic diseases, contributing to public health efforts, and improving the well-being of affected individuals.

MARKET DYNAMICS

The Antiparasitic drugs market is propelled by factors such as the prevalence of parasitic infections, increasing awareness of neglected tropical diseases, and advancements in drug development. The global burden of parasitic diseases, including malaria, leishmaniasis, and helminth infections, drives the demand for effective antiparasitic medications. Government initiatives and international collaborations focusing on eliminating parasitic diseases further contribute to market growth. Research and development efforts to discover novel antiparasitic drugs and the introduction of combination therapies enhance treatment options. The market is also influenced by socioeconomic factors, as parasitic infections disproportionately affect populations in low-income regions. The increasing emphasis on One Health strategies, which acknowledge the interconnectedness of human, animal, and environmental health, highlights the crucial role of antiparasitic drugs in global health initiatives. These medications play a pivotal role in addressing and managing health challenges that transcend species boundaries, contributing to comprehensive efforts aimed at improving overall public health on a global scale.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antiparasitic drugs. The growth and trends of antiparasitic drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the antiparasitic drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease Type

HIV
Hepatitis
By Influenza
TB
Malaria
HPV

By End Use

Hospitals
Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antiparasitic Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antiparasitic Drugs market include Novartis AG., Gilead, GlaxoSmithKline plc., Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ANTIPARASITIC DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Disease Type
- 3.7.2 Market Attractiveness Analysis By End Use
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ANTIPARASITIC DRUGS MARKET ANALYSIS BY DISEASE TYPE

5.1 Overview by Disease Type
5.2 Historical and Forecast Data
5.3 Analysis by Disease Type
5.4 HIV Historic and Forecast Sales by Regions
5.5 Hepatitis Historic and Forecast Sales by Regions
5.6 Influenza Historic and Forecast Sales by Regions
5.7 TB Historic and Forecast Sales by Regions
5.8 Malaria Historic and Forecast Sales by Regions
5.9 HPV Historic and Forecast Sales by Regions

6 . GLOBAL ANTIPARASITIC DRUGS MARKET ANALYSIS BY END USE

6.1 Overview by End Use
6.2 Historical and Forecast Data
6.3 Analysis by End Use
6.4 Hospitals Historic and Forecast Sales by Regions
6.5 Clinics Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL ANTIPARASITIC DRUGS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ANTIPARASITIC DRUGS COMPANIES

8.1. Antiparasitic Drugs Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF ANTIPARASITIC DRUGS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Novartis AG.
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Gilead
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. GlaxoSmithKline plc.
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Janssen Pharmaceutical Inc.
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. F. Hoffmann-La Roche Ltd.
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. BioCryst Pharmaceuticals Inc.
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Merck & Co. Inc.
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Boehringer Ingelheim GmbH.
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments